STAT6 and renal fibrosis: We have also shown that JAK3 inhibitor treatment, or the genetic deletion of STAT6, inhibits M2 macrophage populations and monocyte-to-fibroblast transition, thereby suppressing renal fibrosis in a mouse model of obstructive nephropathy [12].